Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. 

CEO
Joseph J. Ciaffoni
CEOJoseph J. Ciaffoni
Employees
197
Employees197
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
197
Employees197

COLL Key Statistics

Market cap
1.24B
Market cap1.24B
Price-Earnings ratio
31.63
Price-Earnings ratio31.63
Dividend yield
Dividend yield
Average volume
651.59K
Average volume651.59K
High today
$40.87
High today$40.87
Low today
$38.59
Low today$38.59
Open price
$40.87
Open price$40.87
Volume
610.17K
Volume610.17K
52 Week high
$40.95
52 Week high$40.95
52 Week low
$20.83
52 Week low$20.83

COLL News

Simply Wall St 2d
Collegium Pharmaceutical shareholder returns have been stellar, earning 154% in 5 years - Simply Wall St

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far more than 100% on a really good stock. For...

Collegium Pharmaceutical shareholder returns have been stellar, earning 154% in 5 years - Simply Wall St

Analyst ratings

67%

of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.